Cargando…
Development of Personalized Signature Based on the Immune Landscape to Predict the Prognosis of Osteosarcoma and the Response to Immunotherapy and Targeted Therapy
As a heterogeneous and aggressive disease, osteosarcoma (OS) faces great challenges to prognosis and individualized treatment. Hence, we explore the role of immune-related genes in predicting prognosis and responsiveness to immunotherapy and targeted therapies in patients with OS based on the immuno...
Autores principales: | Feng, Xiaofei, Zhao, Zhenrui, Zhao, Yuhao, Song, Zhengdong, Ma, Yao, Wang, Wenji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811188/ https://www.ncbi.nlm.nih.gov/pubmed/35127816 http://dx.doi.org/10.3389/fmolb.2021.783915 |
Ejemplares similares
-
Development and Verification of an Immune-Related Gene Pairs Prognostic Signature in Hepatocellular Carcinoma
por: Feng, Xiaofei, et al.
Publicado: (2021) -
Identification and Development of a Novel 4-Gene Immune-Related Signature to Predict Osteosarcoma Prognosis
por: Cao, Mingde, et al.
Publicado: (2020) -
Identifying a novel cuproptosis-related necroptosis gene subtype-related signature for predicting the prognosis, tumor microenvironment, and immunotherapy of hepatocellular carcinoma
por: Shi, Yuanxin, et al.
Publicado: (2023) -
Development and Verification of a Hypoxic Gene Signature for Predicting Prognosis, Immune Microenvironment, and Chemosensitivity for Osteosarcoma
por: Wu, Fengfeng, et al.
Publicado: (2022) -
Analysis of M2 macrophage-associated risk score signature in pancreatic cancer TME landscape and immunotherapy
por: Yang, Dashuai, et al.
Publicado: (2023)